Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Hiensch, demonstrates that supervised, structured, and Trastuzumab Deruxtecan Shows Promise in Treating HER2-Positive Biliary Tract Cancer Aug 6, 2024 Trastuzumab Deruxtecan Shows Promise in Treating HER2-Positive Biliary Tract Cancer A recent phase II clinical trial conducted across five institutions in Japan has investigated the efficacy of Aspirin reduces the risk of colorectal cancer in individuals with unhealthy lifestyle Aug 2, 2024 Aspirin reduces the risk of colorectal cancer in individuals with unhealthy lifestyle A study published in JAMA Oncology investigated the association between aspirin use and colorectal cancer (CRC) Combining PSMA-PET and PROMISE accurately stratifies high-risk and low-risk groups for overall survival in early and late stages of prostate cancer Jul 31, 2024 Combining PSMA-PET and PROMISE accurately stratifies high-risk and low-risk groups for overall survival in early and late stages of prostate cancer A recent multicentre retrospective study aimed to evaluate the effectiveness of PSMA-PET imaging and the PROMISE Explore content categories
How GLP-1 Medications Work GLP-1 receptor agonists work by mimicking the action of the natural hormone GLP-1, which is involved in regulating blood sugar, appetite, and insulin secretion
An epigenetic study was conducted on CVD due to its significance in inflammation and vascular involvement
The targeted nanocarriers showed significantly higher permeability compared to the non-targeted nanoparticles both in control conditions and in the presence of cytokines
